Abstract
A controlled release pharmaceutical composition comprising a strontium salt. The invention also relates to the use of a strontium salt for treating a male suffering from diseases and conditions affecting metabolism and/or structural integrity of cartilage and/or bone. The invention also relates to the use of a strontium-containing compound for preventing a cartilage and/or bone condition in a subject, and for the treatment and/or prophylaxis of secondary osteoporosis.
| Original language | English |
|---|---|
| Patent number | WO2004098617A3 |
| Priority date | 5/7/03 |
| Filing date | 5/6/04 |
| Publication status | Published - Mar 31 2005 |